• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Derm Disaster

anonymous

Guest
It’s about time all the legacy losers from the Sotyktu launch started leaving and / or getting fired. Everyone knows the overlays are the real bread and butter of Sotyktu, and now that most of us will be getting our own territories, we will teach the old wood from the failed launch a lesson or 2. Just gotta be scrappy to sell this gem. Look out Otezla here we come!!!!
 

<



It’s about time all the legacy losers from the Sotyktu launch started leaving and / or getting fired. Everyone knows the overlays are the real bread and butter of Sotyktu, and now that most of us will be getting our own territories, we will teach the old wood from the failed launch a lesson or 2. Just gotta be scrappy to sell this gem. Look out Otezla here we come!!!!
Shut up Amgen troll